Asl, Maryam Soltani 
; Sorkhabi, Parviz Azimnasab ; Yoshinaga, Túlio Teruo ; Gomes, Cristina de Oliveira Massoco-Salles ; Kfoury Junior, José Roberto
Fonte: Immunologic Research. Unidade: FMVZ
Assuntos: NEOPLASIAS MAMÁRIAS, INIBIDORES DE ENZIMAS, PROCESSOS NEOPLÁSICOS, MODELOS ANIMAIS DE DOENÇAS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
ASL, Maryam Soltani et al. The combination of IDO and AHR blockers reduces the migration and clonogenicity of breast cancer cells. Immunologic Research, 2023Tradução . . Disponível em: https://doi.org/10.1007/s12026-023-09450-9. Acesso em: 06 nov. 2024.APA
Asl, M. S., Sorkhabi, P. A., Yoshinaga, T. T., Gomes, C. de O. M. -S., & Kfoury Junior, J. R. (2023). The combination of IDO and AHR blockers reduces the migration and clonogenicity of breast cancer cells. Immunologic Research. doi:10.1007/s12026-023-09450-9NLM
Asl MS, Sorkhabi PA, Yoshinaga TT, Gomes C de OM-S, Kfoury Junior JR. The combination of IDO and AHR blockers reduces the migration and clonogenicity of breast cancer cells [Internet]. Immunologic Research. 2023 ;[citado 2024 nov. 06 ] Available from: https://doi.org/10.1007/s12026-023-09450-9Vancouver
Asl MS, Sorkhabi PA, Yoshinaga TT, Gomes C de OM-S, Kfoury Junior JR. The combination of IDO and AHR blockers reduces the migration and clonogenicity of breast cancer cells [Internet]. Immunologic Research. 2023 ;[citado 2024 nov. 06 ] Available from: https://doi.org/10.1007/s12026-023-09450-9
